In vitro inhibition of this protein, either by silencing or chemical agent results in PD-L1 down modulation in glioblastoma cells lines and, as a consequence, the suppressive effect exerted by the tumour on immune cells is relieved. This evidence concerns the gene CD274 and glioblastoma.